The clinical impact of proliferative high-risk lesions presenting concurrently with ductal carcinoma in situ (OCIS) in patients (pts) treated with breast conserving therapy (BCT).

被引：0
|
作者：
Adepoju, LJ [1 ]
Symmans, WF [1 ]
Babiera, GV [1 ]
Singletary, SE [1 ]
Sneige, N [1 ]
Buchholz, TA [1 ]
Hunt, KK [1 ]
Meric-Bernstam, F [1 ]
Arun, B [1 ]
Kuerer, HM [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：36S / 36S
页数：1
相关论文
共 50 条
  • [1] Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Adepoju, LJ
    Symmans, WF
    Babiera, GV
    Singletary, SE
    Arun, B
    Sneige, N
    Pusztai, L
    Buchholz, TA
    Sahin, A
    Hunt, KK
    Meric-Bernstam, F
    Ross, MI
    Ames, FC
    Kuerer, HM
    CANCER, 2006, 106 (01) : 42 - 50
  • [2] Pathology of high-risk breast lesions and ductal carcinoma in situ
    Sewell, CW
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2004, 42 (05) : 821 - +
  • [3] Impact of surgery-to-radiotherapy interval (SRI) on local control in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving therapy (BCT)
    Thurman, SA
    Schnitt, SJ
    Connolly, JL
    Gelman, R
    Silver, B
    Harris, JR
    Recht, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S382 - S383
  • [4] The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ
    Lee, David Y.
    Lewis, Jana L.
    Wexelman, Barbara A.
    Freedman, Beth C.
    Ross, Ronald E.
    Tartter, Paul I.
    AMERICAN JOURNAL OF SURGERY, 2013, 206 (05): : 790 - 797
  • [5] Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy
    Vicini, FA
    Kestin, LL
    Goldstein, NS
    Chen, PY
    Pettinga, J
    Frazier, RC
    Martinez, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 296 - 306
  • [6] Impact of Race and Ethnicity on Recurrence Risk in Patients with Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery
    Polidorio, Natalia
    Jones, V. Morgan
    Sevilimedu, Varadan
    Morrow, Monica
    Van Zee, Kimberly J.
    Barrio, Andrea V.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S49 - S49
  • [7] Impact of Race and Ethnicity on Recurrence Risk in Patients with Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery
    Polidorio, Natalia
    Jones, V. Morgan
    Sevilimedu, Varadan
    Morrow, Monica
    Van Zee, Kimberly
    Barrio, Andrea
    CANCER RESEARCH, 2024, 84 (09)
  • [8] Impact of Microinvasion as a Predictor of Local Recurrence in Ductal Carcinoma In Situ Treated With Breast Conserving Therapy
    Lalani, N.
    Paszat, L.
    Sutradhar, R.
    Gu, S.
    Fong, C.
    Nofech-Mozes, S.
    Hanna, W.
    Tuck, A.
    Youngson, B.
    Miller, N.
    Done, S. J.
    Chang, M. C.
    Sengupta, S.
    Elavathil, L.
    Jani, P.
    Bonin, M.
    Rakovitch, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E27 - E27
  • [9] Correlation of concurrent lobular neoplasia (LN) and ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving therapy (BCT)
    Rudloff, U.
    Brogi, E.
    Brockway, J. P.
    Wynveen, C. A.
    Nehhozina, T.
    Reiner, A.
    Patil, S.
    Van Zee, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Microinvasion is not associated with an increased risk of local recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Rakovitch, E.
    Pignol, J-P
    Hanna, W.
    Chartier, C.
    Kahn, H.
    Wong, J.
    Paszat, L.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S69 - S69
12345